2nd Quarter - Report

MEHLMAN CONSULTING, INC. for ASSOCIATION OF ACCESSIBLE MEDICINES

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Blocking Act and supply chain issues. H.R. 5376 - Build Back Better Act. S. 3799 - PREVENT Pandemics Act. H.R. 7667 - The Food and Drug Amendments of 2022. S. 4338 - FDA Safety and Landmark Advancements Act (FDASLA).

Contacted: White House Office; Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: S. 3799 (117th), H.R. 7667 (117th), S. 4338 (117th), H.R. 5376 (117th)

Medicare/Medicaid MMM

Medicaid generic rebate policy; Medicare low-income subsidy (LIS) rebate. H.R. 5376 - Build Back Better Act.

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); White House Office; Health & Human Services, Dept of (HHS)

Bills named: H.R. 5376 (117th)

Copyright/Patent/Trademark CPT

Issues related to the sovereign immunity for patent protection. Issues related to patents and inter partes review.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

Indo-Pacific Economic Partnership. Issues related to Supply Chain Policy. S. 1260 - U.S. Innovation and Competition Act. H.R.4521 - America COMPETES Act of 2022.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4521 (117th), S. 1260 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.